Anzeige
Mehr »
Login
Sonntag, 04.12.2022 Börsentäglich über 12.000 News von 678 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2ABUC ISIN: AU000000RSH4 Ticker-Symbol: S9T 
Berlin
02.12.22
08:08 Uhr
0,024 Euro
+0,001
+4,44 %
Branche
Gesundheitswesen
Aktienmarkt
AUSTRALIEN
1-Jahres-Chart
RESPIRI LIMITED Chart 1 Jahr
5-Tage-Chart
RESPIRI LIMITED 5-Tage-Chart

Aktuelle News zur RESPIRI Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoRespiri - Commercialization efforts gathering steam190The Respiri/Access Telehealth collaboration continues to make steady gains in the US with the partners announcing their fourth commercial deal to date, with Arkansas Heart Hospital (AHH), a healthcare...
► Artikel lesen
MoASX Health Stocks: FDA greenlights Anteris study, Respiri selected in Arkansas1
21.11.Respiri: wheezo-Atemsensor und Patienten-Fernüberwachung für Pilotprogramm des Minnesota Lung Center ausgewählt1
18.11.Respiri - Wheezo bags third client win in the US272Respiri continues to expand its commercial footprint in the United States with the signing of another client account, with Minnesota Lung Center (MLC), for an initial three-month pilot study assessing...
► Artikel lesen
18.11.Respiri's wheezo and RPM solution selected for MLC pilot program1
16.11.RESPIRI LIMITED: Minnesota Lung Centre select wheezo and RMP for pilot prog.-
15.11.RESPIRI LIMITED: Constitution-
15.11.RESPIRI LIMITED: Results of 2022 Annual General Meeting2
RESPIRI Aktie jetzt für 0€ handeln
15.11.RESPIRI LIMITED: Chairman and CEO's Presentation to Shareholders-
08.11.Respiri recruits first patients in US wheezo programme-
06.11.RESPIRI LIMITED: Key milestone - First patients enrol into wheezo RPM program-
25.10.RESPIRI LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report-
16.10.RESPIRI LIMITED: Notice of Annual General Meeting/Proxy Form-
11.10.RESPIRI LIMITED: Notification of cessation of securities - RSH-
09.10.RESPIRI LIMITED: Disclosure Document - Cleansing Notice-
07.10.RESPIRI LIMITED: Application for quotation of securities - RSH-
06.10.Respiri - Focus on cost optimisation218To support an optimal roll-out of its US commercialisation strategy for its wheezo device, Respiri recently announced several cost-saving initiatives, the latest being a reduction in the CEO's and executive...
► Artikel lesen
05.10.RESPIRI LIMITED: Cost optimisation with senior executive remuneration-
30.09.RESPIRI LIMITED: Respiri commences trading on the OTCQB-
29.09.RESPIRI LIMITED: Update - Proposed issue of securities - RSH-
Seite:  Weiter >>
52 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1